The science behind the MonaLisa Touch

The science behind the MonaLisa Touch

Originating in Italy, the MonaLisa Touch has been used in Australia since 2013. It has gained popularity due to its effectiveness in treating vaginal atrophy (the thinning of the vaginal walls) and urinary symptoms. Vaginal atrophy can cause symptoms of vaginal dryness, itchiness, painful sex, stress incontinence, reoccurring urinary tract infections – now known in medical circles as genitourinary syndrome of menopause – GSM. MonaLisa Touch is also effective in treating post-childbirth vaginal laxity and stress incontinence.


What does it do?
The MonaLisa Touch uses a fractional laser to stimulate vaginal tissue health. A fractional laser is one that is split into thousands of microscopic ‘dots’ – these dots create miniscule holes into the vaginal lining, stimulating new vaginal tissue growth. This non-invasive procedure has been shown to remove minute ‘columns’ of vaginal wall which in turn facilitates the rejuvenation of the surrounding tissue. In most cases, this new tissue growth reduces the symptoms experienced by the patient and, in some cases, alleviates them completely.

What does the research say?
There have been several studies regarding this procedure, including a 2014 pilot study that tracked the treatment of 50 women over the course of 12 weeks. At the conclusion of the study, 84% of patients reported success and satisfaction with the treatment.

A related study, conducted in 2015, looked at sexual function in non-sexually active postmenopausal women. Researchers found that 85% of participants had regained normal sexual activity after treatment.

More recently, researchers at the University of Turin assessed 87 women who received treatment over the course of 15 months, concluding that fractional laser offers a “significant and long-lasting improvement of vaginal atrophy symptoms”.

In Australia, a large-scale study found that 84% of the 102 Australian women, who underwent treatment experienced significant improvement in their symptoms. To support these findings, a randomised trial conducted by the Department of Gynaecology at Royal Hospital for Women is currently underway and results will be available shortly.

As a result of the above studies, treatment using fractional lasers for vaginal atrophy is now offered at prestigious hospitals around the world including the John Hopkins Hospital in America, and a recent article published by the Harvard Medical School officially recommended the procedure for vaginal and urinary issues after menopause.

The Jade Room patients have reported success in treating conditions such as post-cancer and menopausal vaginal atrophy, vaginal dryness, stress incontinence, and post-childbirth weakened vaginal walls.

The Jade Room offers clients a safe and confidential service. As a new patient, each new treatment begins with a consultation with a doctor and a full explanation of the process. To read more about our client experiences, see The Jade Room blog.


No referral necessary to see our women’s health doctor.


Book A Free Consultation Now!